KPC’s continuous technical innovation has brought us the crystal-clear Xuesaitong soft capsules. The soft capsules overcome the problem of poor absorption previously found in oral preparations of panax notoginseng saponins (PNS). Since 1996, KPC has been developing the Xuesaitong soft capsule. It was awarded the patent in 2003 and formally launched onto the market in 2005. In 2013, it has been on the Protection List of Traditional Chinese Medicine. To ensure the high saponin content and high purity of Luotai^® Xuesaitong soft capsules, KPC only uses ingredients from KPC GAP Planting Base in Wenshan, Yunnan and only extracts from the basal part of the stem, which contains the most saponins. The total saponin content of Luotai® Xuesaitong soft capsules is more than 85%, which is 10% higher than that defined in the national standard.